Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Cancer Research|February 4, 2016
Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote MetastasisLong-Yun Ye, Wei Chen, Xue-Li Bai, et al.Molecular Cancer Therapeutics|May 29, 2014
Inhibition of protein phosphatase 2A enhances cytotoxicity and accessibility of chemotherapeutic drugs to hepatocellular carcinomasXue-Li Bai, Qi Zhang, Long-Yun Ye, et al.World Journal of Gastroenterology|September 17, 2013
Acute iatrogenic Budd-Chiari syndrome following hepatectomy for hepatolithiasis: a report of two casesXue-Li Bai, Yi-Wen Chen, Qi Zhang, et al.Cancer Letters|September 27, 2023
Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinomaTian-Jiao Li, Kai-Zhou Jin, Hong-Yu Zhou, et al.The FEBS Journal|May 28, 2023
Inhibition of epithelial-to-mesenchymal transition augments antitumor efficacy of nanotherapeutics in pancreatic ductal adenocarcinomaKai-Zhou Jin, Ying Wu, Xiao-Xiao Zheng, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 19, 2017
Hook1 inhibits malignancy and epithelial-mesenchymal transition in hepatocellular carcinomaXu Sun, Qi Zhang, Wei Chen, et al.The Journal of Clinical Endocrinology and Metabolism|April 15, 2020
Tumor-Infiltrating Neutrophils Predict Poor Survival of Non-Functional Pancreatic Neuroendocrine TumorWu-Hu Zhang, Wen-Quan Wang, He-Li Gao, et al.Computational and Structural Biotechnology Journal|December 11, 2020
Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspectiveWu-Hu Zhang, Wen-Quan Wang, Xuan Han, et al.Journal for Immunotherapy of Cancer|October 15, 2020
Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumorsWu-Hu Zhang, Wen-Quan Wang, Xuan Han, et al.Journal of Gastroenterology|March 20, 2021
A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumorsWen-Quan Wang, Wu-Hu Zhang, He-Li Gao, et al.Pageof 3